Welcome to this UK AstraZeneca produced and funded website
This website is intended for UK Healthcare Professionals only.
The website contains both promotional and non-promotional content.
If you are a patient or a carer of a patient prescribed an AstraZeneca product, please visit myazmed.co.uk
For any other UK residents please visit astrazeneca.co.uk
This website is intended for UK Healthcare Professionals only. Other UK residents please visit astrazeneca.co.uk
Please do not share this webpage with patients.
Prescribing information can be found at the top of the page. Adverse Event reporting links can be found at the bottom of the page.
Indication statement can be found here.
Here you can access educational materials and videos hosted by experts in the field of asthma and you can listen them at your convenience.
These videos have been organised and funded by AstraZeneca and contain mentioning of AstraZeneca’s products.
Patient materials should be downloaded and shared with patients separately.
We have developed a number of resources for your patients to support them to better understand, monitor and manage their condition, symptoms and treatment.
Fields marked with * are mandatory
Note: Your personal details will not be used for any promotional purposes without your explicit consent. More details can be found in our Privacy Policy.
If you wish to order hard copy materials, please submit the form below:
Your request is being processed; the items selected will be delivered as soon as possible.
Please make sure the delivery point is expecting your support materials.
Should you have any questions, check contact us.
DPI, Dry powder lnhaler; GP, General practitioner; HCP, Healthcare professional; ICS, Inhaled Corticosteroid; LABA, Long-acting β2 agonist; MART, Maintenance and Reliever Therapy; NHS, National Health Service; pMDI, Pressurised metered dose Inhalers; Q&A, Questions and answers; SABA, Short-acting β2 agonists; SmPC, Summary of Product Characteristics.
GB-69717 | DOP: December 2025
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. Adverse events should also be reported to AstraZeneca by visiting https://contactazmedical.astrazeneca.com/ or by calling 0800 783 0033.
This website was created for UK HCPs and has been designed to provide information to educate, empower and enable them in the great work they are doing for patients across a range of therapy areas. This website is intended for doctors, nurses, and pharmacists in the UK. Other UK residents please visit astrazeneca.co.uk.
